Connect with us

Headlines

Essilor-Luxottica Deal Gets US and European Approval

mm

Published

on

The deal is expected to close in the ‘first part of 2018.’

CHARENTON-LE-PONT, FRANCE and MILAN, ITALY – Essilor and Luxottica announce that their proposed merger has received the OK from authorities in both the U.S. and Europe.

The deal was approved by the U.S. Federal Trade Commission and the European Commission without conditions.
To date, the transaction has also been unconditionally approved in 13 other countries: Australia, Canada, Chile, Colombia, India, Japan, Mexico, Morocco, New Zealand, Russia, South Africa, South Korea and Taiwan.

The merger is expected to be finalized in the first part of 2018. The Financial Times reports that one major remaining step is securing approval from antitrust regulators in China.

Milan, Italy-based Luxottica’s proposed deal with Essilor, a France-based maker of lenses as well as instruments and equipment, is valued at 48 billion euros (U.S. $56.5 billion). The combined company would be called EssilorLuxottica.

Advertisement

SPONSORED VIDEO

Meet the Next Generation of Smart Glasses

Ray-Ban Meta is now available with a full range of lenses, as a complete pair or edged lens. Prescription orders eligible through select insurance providers, including Eyemed and private pay. The Ray-Ban Meta collection combines iconic design with cutting-edge technology. Capture life’s best moments and livestream to Facebook and Instagram with an upgraded 12 MP camera and five-mic system. Stay connected with hands-free calls and messages. Listen to your favorite tracks through built-in speakers. Spark your creativity, get information and control your glasses with your voice – powered by Meta AI. All while keeping your phone in your pocket. For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular